Wealth Enhancement Advisory Services’s Wave Life Sciences WVE Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$213K	Buy	+34,110	New	+$226K	﹤0.01%	3529

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Wealth Enhancement Advisory Services's WVE Position: Q2 2026 in Review

Wealth Enhancement Advisory Services opened a new position in Wave Life Sciences (WVE) in Q2 2026: 34,110 shares worth $213K. The stake represents ﹤0.01% of the portfolio and ranks #3529 among its holdings.

239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

Wealth Enhancement Advisory Services held 34,110 shares of Wave Life Sciences worth $213K as of Q2 2026.
Wave Life Sciences was a new Wealth Enhancement Advisory Services position in Q2 2026.
Wave Life Sciences made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3529 holding.
239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.